173 related articles for article (PubMed ID: 11243726)
1. A sequence variation in the mitochondrial glycerol-3-phosphate dehydrogenase gene is associated with increased plasma glycerol and free fatty acid concentrations among French Canadians.
St-Pierre J; Vohl MC; Brisson D; Perron P; Després JP; Hudson TJ; Gaudet D
Mol Genet Metab; 2001 Mar; 72(3):209-17. PubMed ID: 11243726
[TBL] [Abstract][Full Text] [Related]
2. [The impact of calpain-10 gene combined-SNP variation on type 2 diabetes mellitus and its related metabolic traits].
Xiang K; Fang Q; Zheng T; Jia W; Wang Y; Zhang R; Li J; Shen K
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Dec; 18(6):426-30. PubMed ID: 11774208
[TBL] [Abstract][Full Text] [Related]
3. Effects of breakfast meal composition on second meal metabolic responses in adults with Type 2 diabetes mellitus.
Clark CA; Gardiner J; McBurney MI; Anderson S; Weatherspoon LJ; Henry DN; Hord NG
Eur J Clin Nutr; 2006 Sep; 60(9):1122-9. PubMed ID: 16670695
[TBL] [Abstract][Full Text] [Related]
4. Calcium activation of mitochondrial glycerol phosphate dehydrogenase restudied.
MacDonald MJ; Brown LJ
Arch Biochem Biophys; 1996 Feb; 326(1):79-84. PubMed ID: 8579375
[TBL] [Abstract][Full Text] [Related]
5. Resistin gene 3'-untranslated region +62G-->A polymorphism is associated with hypertension but not diabetes mellitus type 2 in a German population.
Gouni-Berthold I; Giannakidou E; Faust M; Kratzsch J; Berthold HK; Krone W
J Intern Med; 2005 Dec; 258(6):518-26. PubMed ID: 16313475
[TBL] [Abstract][Full Text] [Related]
6. Association between the PPARalpha L162V polymorphism, plasma lipoprotein levels, and atherosclerotic disease in patients with diabetes mellitus type 2 and in nondiabetic controls.
Gouni-Berthold I; Giannakidou E; Müller-Wieland D; Faust M; Kotzka J; Berthold HK; Krone W
Am Heart J; 2004 Jun; 147(6):1117-24. PubMed ID: 15199365
[TBL] [Abstract][Full Text] [Related]
7. The Pro12Ala polymorphism of the PPAR-gamma2 gene affects associations of fish intake and marine n-3 fatty acids with glucose metabolism.
Ylönen SK; Salminen I; Lyssenko V; Virtanen SM; Groop L; Aro A; Saloranta C;
Eur J Clin Nutr; 2008 Dec; 62(12):1432-9. PubMed ID: 17700648
[TBL] [Abstract][Full Text] [Related]
8. Decreased whole body lipolysis as a mechanism of the lipid-lowering effect of pioglitazone in type 2 diabetic patients.
Gastaldelli A; Casolaro A; Ciociaro D; Frascerra S; Nannipieri M; Buzzigoli E; Ferrannini E
Am J Physiol Endocrinol Metab; 2009 Jul; 297(1):E225-30. PubMed ID: 19417125
[TBL] [Abstract][Full Text] [Related]
9. Low fasting serum triglyceride and high free fatty acid levels in pulmonary fibrosis: a previously unreported finding.
Iannello S; Cavaleri A; Camuto M; Pisano MG; Milazzo P; Belfiore F
MedGenMed; 2002 Jun; 4(2):5. PubMed ID: 12145565
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor alpha -238G>A genotype alters postprandial plasma levels of free fatty acids in obese individuals with type 2 diabetes mellitus.
Fontaine-Bisson B; Wolever TM; Chiasson JL; Rabasa-Lhoret R; Maheux P; Josse RG; Leiter LA; Rodger NW; Ryan EA; El-Sohemy A
Metabolism; 2007 May; 56(5):649-55. PubMed ID: 17445540
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and clinical phenotype of the p.Val226Met glucokinase gene mutation in French Canadians in Quebec, Canada.
Henderson M; Levy E; Delvin E; Losekoot M; Lambert M
Mol Genet Metab; 2007 Jan; 90(1):87-92. PubMed ID: 17079173
[TBL] [Abstract][Full Text] [Related]
12. Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes.
Kotronen A; Juurinen L; Tiikkainen M; Vehkavaara S; Yki-Järvinen H
Gastroenterology; 2008 Jul; 135(1):122-30. PubMed ID: 18474251
[TBL] [Abstract][Full Text] [Related]
13. Genetic variation in thioredoxin interacting protein (TXNIP) is associated with hypertriglyceridaemia and blood pressure in diabetes mellitus.
van Greevenbroek MM; Vermeulen VM; Feskens EJ; Evelo CT; Kruijshoop M; Hoebee B; van der Kallen CJ; de Bruin TW
Diabet Med; 2007 May; 24(5):498-504. PubMed ID: 17381501
[TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-activated receptor (PPAR) delta genetic polymorphism and its association with insulin resistance index and fasting plasma glucose concentrations in Chinese subjects.
Hu C; Jia W; Fang Q; Zhang R; Wang C; Lu J; Xiang K
Diabet Med; 2006 Dec; 23(12):1307-12. PubMed ID: 17116180
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor alpha is associated with insulin-mediated suppression of free fatty acids and net lipid oxidation in HIV-infected patients with lipodystrophy.
Haugaard SB; Andersen O; Pedersen SB; Dela F; Fenger M; Richelsen B; Madsbad S; Iversen J
Metabolism; 2006 Feb; 55(2):175-82. PubMed ID: 16423623
[TBL] [Abstract][Full Text] [Related]
16. Hepatic fat is not associated with beta-cell function or postprandial free fatty acid response.
Rijkelijkhuizen JM; Doesburg T; Girman CJ; Mari A; Rhodes T; Gastaldelli A; Nijpels G; Dekker JM
Metabolism; 2009 Feb; 58(2):196-203. PubMed ID: 19154952
[TBL] [Abstract][Full Text] [Related]
17. Impact of the Thr789Ala variant of the von Willebrand factor levels, on ristocetin co-factor and collagen binding capacity and its association with coronary heart disease in patients with diabetes mellitus type 2.
Klemm T; Mehnert AK; Siegemund A; Wiesner TD; Gelbrich G; Blüher M; Paschke R
Exp Clin Endocrinol Diabetes; 2005 Dec; 113(10):568-72. PubMed ID: 16320153
[TBL] [Abstract][Full Text] [Related]
18. Time-dependent effects of free fatty acids on glucose effectiveness in type 2 diabetes.
Kishore P; Tonelli J; Koppaka S; Fratila C; Bose A; Lee DE; Reddy K; Hawkins M
Diabetes; 2006 Jun; 55(6):1761-8. PubMed ID: 16731840
[TBL] [Abstract][Full Text] [Related]
19. Metabolic changes following sibutramine-assisted weight loss in obese individuals: role of plasma free fatty acids in the insulin resistance of obesity.
McLaughlin T; Abbasi F; Lamendola C; Kim HS; Reaven GM
Metabolism; 2001 Jul; 50(7):819-24. PubMed ID: 11436188
[TBL] [Abstract][Full Text] [Related]
20. Elevated fasting insulin concentrations associate with impaired insulin signaling in skeletal muscle of healthy subjects independent of obesity.
Korsheninnikova E; Seppälä-Lindroos A; Vehkavaara S; Goto T; Virkamäki A
Diabetes Metab Res Rev; 2002; 18(3):209-16. PubMed ID: 12112939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
